Showing results (691-700 of 3,200) with videos related to
Sort By:
Pageof 320
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000)Ana C Gales, Helio S Sader, Ronald N Jones, et al.Psychopharmacologia|January 1, 1976
Temporal parameters of d-amphetamine as a discriminative stimulus in the ratC N Jones, L D Grant, D M VospalekThe Annals of Pharmacotherapy|December 31, 2002
CANCER resistance surveillance program: initial results from hematology-oncology centers in North America. Chemotherapy Alliance for Neutropenics and the Control of Emerging ResistanceAlan H Mutnick, Jeffrey T Kirby, Ronald N Jones, et al.Journal of Chemotherapy (Florence, Italy)|July 18, 2002
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information CollectionA H Mutnick, P J Turner, R N JonesDiagnostic Microbiology and Infectious Disease|June 8, 2002
AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strainsR N Jones, T R Anderegg, L M DeshpandeCancer Cell|May 26, 2012
ATM phosphorylation of Mdm2 Ser394 regulates the amplitude and duration of the DNA damage response in miceHugh S Gannon, Bruce A Woda, Stephen N JonesApplied Neuropsychology|August 18, 2011
Learning characteristics of the CERAD word list in an elderly VA sampleScott N Jones, Ashley J Greer, David E CoxBehavioral Medicine (Washington, D.C.)|September 8, 2011
Smoking, depression, and gender in low-income African Americans with HIV/AIDSDiana W Stewart, Glenn N Jones, Kyle S MinorJournal of Clinical Microbiology|November 21, 2014
Validation of a commercial dry-form broth microdilution device (Sensititre) for testing tedizolid, a new oxazolidinoneRonald N Jones, Nicole M Holliday, Paul R RhombergDiagnostic Microbiology and Infectious Disease|May 26, 1999
Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organismsK C Kugler, D J Biedenbach, R N JonesPageof 320